UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 79

Sortiert nach

Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia: a randomized phase 3 trial with 5-year outcomes

Journal of cancer research and clinical oncology, 2024-04, Vol.150 (4), p.189, Article 189

2024

Volltextzugriff (PDF)

Current Treatment Patterns of Aplastic Anemia in China: A Prospective Cohort Registry Study

Acta haematologica, 2019-09, Vol.142 (3), p.162-170

2019

Volltextzugriff (PDF)

Imatinib compared with second‐generation tyrosine kinase‐inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase

American journal of hematology, 2023-07, Vol.98 (7), p.E183-E186

2023

Volltextzugriff (PDF)

Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood

Annals of hematology, 2013, Vol.92 (1), p.89-96

2013

Volltextzugriff (PDF)

Effects of imatinib mesylate on the levels of endocrine hormones

Zhōnghuá xuèyèxué zázhì, 2013-09, Vol.34 (9), p.762-766

2013

Volltextzugriff (PDF)

Clinical Efficacy of Second-generation Tyrosine Kinase Inhibitor in Treating Chronic Myeloid Leukemia

Sichuan da xue xue bao. Journal of Sichuan University. Yi xue ban, 2016-03, Vol.47 (2), p.287-291

2016

Volltextzugriff (PDF)

Efficacy of tyrosine kinase inhibitor in treatment of chronic myeloid leukemia patients

Sichuan da xue xue bao. Journal of Sichuan University. Yi xue ban, 2014-07, Vol.45 (4), p.647-651

2014

Volltextzugriff (PDF)

Effect of Antiviral Prophylaxis Strategy for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin’s Lymphoma Patients with Hepatitis B Virus Infection: A Retrospective Cohort Study

Indian journal of hematology & blood transfusion, 2014-06, Vol.30 (2), p.97-104

2014

Volltextzugriff (PDF)

Early detection of MRD in peripheral blood after induction chemotherapy of newly diagnosed patients with AML and its correlation with curative effects

Zhongguo shi yan xue ye xue za zhi, 2013-02, Vol.21 (1), p.57

2013

Volltextzugriff (PDF)

Flow cytometric analysis of cerebrospinal fluid in the diagnosis of central nervous system leukemia

Sichuan da xue xue bao. Journal of Sichuan University. Yi xue ban, 2010-07, Vol.41 (4), p.664

2010

Volltextzugriff (PDF)

Influence of hOCT1 polymorphism on imatinib mesylate effectiveness in chronic myelogenous leukemia patients

Zhōnghuá xuèyèxué zázhì, 2009-09, Vol.30 (9), p.596-600

2009

Volltextzugriff (PDF)

Establishment of an imatinib resistance cell line K562R and its resistant principia

Sichuan da xue xue bao. Journal of Sichuan University. Yi xue ban, 2007-01, Vol.38 (1), p.22

2007

Volltextzugriff (PDF)

Role of gammadeltaT cells in pathogenesis of acquired pure red cell aplastic anemia

Zhongguo shi yan xue ye xue za zhi, 2007-02, Vol.15 (1), p.142

2007

Volltextzugriff (PDF)

Overview of chronic myelogenous leukemia and its current diagnosis and treatment patterns in 15 hospitals in China.

Zhōnghuá xuèyèxué zázhì, 2009-11, Vol.30 (11), p.721-725

2009

Volltextzugriff (PDF)

Effect of arsenic trioxide on bone marrow stromal cells of patients with multiple myeloma

Zhongguo shi yan xue ye xue za zhi, 2006-04, Vol.14 (2), p.258

2006

Volltextzugriff (PDF)

Results from a Phase 2 Study of a Novel Janus Kinase Inhibitor in Treatment of Patients with Myelofibrosis

Blood, 2021-11, Vol.138 (Supplement 1), p.387-387

2021

Volltextzugriff (PDF)

Immune regulatory effect of human bone marrow mesenchymal stem cells on T lymphocyte

Zhongguo shi yan xue ye xue za zhi, 2005-08, Vol.13 (4), p.651

2005

Volltextzugriff (PDF)

Analysis of T cell subsets and CD3zeta chain expression in myelodysplastic syndrome patients

Zhongguo shi yan xue ye xue za zhi, 2004-12, Vol.12 (6), p.779

2004

Volltextzugriff (PDF)

A paired case-control study for assessing the relationship between the incidence of malignant lymphomas and the viruses infections

Sichuan da xue xue bao. Journal of Sichuan University. Yi xue ban, 2004-03, Vol.35 (2), p.247

2004

Volltextzugriff (PDF)

Outcome with Hyper-CVAD/MTX-Ara-C, a Dose-Intensive Regimen, in Acute Lymphocytic Leukemia and Highly Aggressive Lymphoma in China

Blood, 2007-11, Vol.110 (11), p.4328-4328

2007

Volltextzugriff (PDF)

Outcome with Hyper-CVAD/MTX-Ara-C, a Dose-Intensive Regimen, in Acute Lymphocytic Leukemia and Highly Aggressive Lymphoma: A Preliminary Study in a Single Center in China

Blood, 2006-11, Vol.108 (11), p.4529-4529

2006

Volltextzugriff (PDF)

Expression of hOCT1 in patients with chronic myelogeneous leukemia treated by imatinib mesylate

Sichuan da xue xue bao. Journal of Sichuan University. Yi xue ban, 2009-09, Vol.40 (5), p.893

2009

Volltextzugriff (PDF)

MMP-9 expression profile in inflammatory cells of Mip-1alpha knockout mice and Mip-1alpha receptor knockout mice

Sichuan da xue xue bao. Journal of Sichuan University. Yi xue ban, 2009-05, Vol.40 (3), p.374

2009

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(66)

Publikationsform

Artikel
(78)
Dissertationen
(1)

Sprache

Chinesisch
(40)
Englisch
(39)

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Humans
(22)
Life Sciences & Biomedicine
(17)
Female
(14)
Male
(14)
Adult
(11)
Aged
(11)
Middle Aged
(11)
Adolescent
(9)
Imatinib Mesylate
(7)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(7)
Physical Sciences
(7)
Young Adult
(7)
Flow Cytometry
(6)
Hematology
(6)
Oncology
(6)
Animals
(5)
Child
(5)
China
(5)
Piperazines - Therapeutic Use
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia: a randomized phase 3 trial with 5-year outcomes

Current Treatment Patterns of Aplastic Anemia in China: A Prospective Cohort Registry Study

Imatinib compared with second‐generation tyrosine kinase‐inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase

Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood

Effects of imatinib mesylate on the levels of endocrine hormones

Standardized fluorescence in situ hybridization testing based on an appropriate panel of probes more effectively identifies common cytogenetic abnormalities in myelodysplastic syndromes than conventional cytogenetic analysis: A multicenter prospective study of 2302 patients in China

Clinical Efficacy of Second-generation Tyrosine Kinase Inhibitor in Treating Chronic Myeloid Leukemia

Efficacy of tyrosine kinase inhibitor in treatment of chronic myeloid leukemia patients

Effect of Antiviral Prophylaxis Strategy for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin’s Lymphoma Patients with Hepatitis B Virus Infection: A Retrospective Cohort Study

Early detection of MRD in peripheral blood after induction chemotherapy of newly diagnosed patients with AML and its correlation with curative effects

Flow cytometric analysis of cerebrospinal fluid in the diagnosis of central nervous system leukemia

Influence of hOCT1 polymorphism on imatinib mesylate effectiveness in chronic myelogenous leukemia patients

Establishment of an imatinib resistance cell line K562R and its resistant principia

Role of gammadeltaT cells in pathogenesis of acquired pure red cell aplastic anemia

Overview of chronic myelogenous leukemia and its current diagnosis and treatment patterns in 15 hospitals in China.

Effect of arsenic trioxide on bone marrow stromal cells of patients with multiple myeloma

Results from a Phase 2 Study of a Novel Janus Kinase Inhibitor in Treatment of Patients with Myelofibrosis

Immune regulatory effect of human bone marrow mesenchymal stem cells on T lymphocyte

Analysis of T cell subsets and CD3zeta chain expression in myelodysplastic syndrome patients

A paired case-control study for assessing the relationship between the incidence of malignant lymphomas and the viruses infections

Interim Results of a Multi-Center Observational Study of Current Treatment Patterns for Patients with Severe Aplastic Anemia (SAA), Very Severe Aplastic Anemia (VSAA) and Transfusion-Dependent Non-Severe Aplastic Anemia (TD-NSAA) in China

Outcome with Hyper-CVAD/MTX-Ara-C, a Dose-Intensive Regimen, in Acute Lymphocytic Leukemia and Highly Aggressive Lymphoma in China

Outcome with Hyper-CVAD/MTX-Ara-C, a Dose-Intensive Regimen, in Acute Lymphocytic Leukemia and Highly Aggressive Lymphoma: A Preliminary Study in a Single Center in China

Expression of hOCT1 in patients with chronic myelogeneous leukemia treated by imatinib mesylate

MMP-9 expression profile in inflammatory cells of Mip-1alpha knockout mice and Mip-1alpha receptor knockout mice

Suchergebnisse filtern